Mice primed and boosted with HER2-expressing oHSV-1 also generated an anti-HER2 systemic cellular response, resulting in enhanced tumor regression compared to mice primed and boosted with HER2 non-expressing oHSV-1. The gene discussed is ERBB2; the disease is neoplasm.